Status: Recruiting
HRS-4642 Combination With Other Antitumor Therapies in Patients With Solid Tumors
This study is a randomized, open-label, multicenter Phase II clinical trial designed to evaluate the Safety, Tolerability and Preliminary Efficacy of HRS-4642 Combination with Other Antitumor Therapies in Patients with Solid Tumors
Participants needed: 60
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Shanghai Hengrui Pharmaceutical Co., Ltd.Updated: Jan 14, 2026Locations: 1
Eligibility criteria
Age range of 18-75 years old (inclusive of both ends), gender not limited when s... [+5]
Accompanied by untreated or active central nervous system (CNS) tumor metastasis [+4]